Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$647,745
-$65,829 QoQ
Shares Held
5,127
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,263
of 2,266 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SAGE RHINO CAPITAL LLC holds $11,215,095 across 12 Drug Manufacturers - General names. GILD ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,014 | $2,415,652 | |
| 2 | JNJ |
Johnson & Johnson
|
6,868 | $1,744,265 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,448 | $1,342,568 | |
| 4 | NVS |
Novartis AG
|
7,947 | $1,245,453 | |
| 5 | AZN |
Astrazeneca PLC
|
5,336 | $1,011,812 | |
| 6 | AMGN |
Amgen Inc
|
2,387 | $864,380 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
5,127 | $647,745 | |
| 8 | ABBV |
AbbVie Inc.
|
2,265 | $569,964 |
All Filings in GILD
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $647,745 | 5,127 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $713,574 | 5,120 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $811,679 | 6,613 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $821,400 | 7,400 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $261,542 | 2,359 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $256,146 | 2,286 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $208,756 | 2,260 | Shares | Sole | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||